Coloplast A/S Sponsored ADR (CLPBY)
(Delayed Data from OTC)
$12.22 USD
-0.06 (-0.49%)
Updated May 13, 2024 03:59 PM ET
4-Sell of 5 4
C Value C Growth F Momentum D VGM
Income Statements
Fiscal Year end for Coloplast AS Sponsored ADR falls in the month of September.
All items in Millions except EPS data.
9/30/23 | 9/30/22 | 9/30/21 | 9/30/20 | 9/30/19 | |
---|---|---|---|---|---|
Sales | 3,513 | 3,292 | 3,122 | 2,785 | 2,711 |
Cost Of Goods | 1,172 | 1,028 | 982 | 891 | 874 |
Gross Profit | 2,341 | 2,264 | 2,139 | 1,894 | 1,836 |
Selling & Adminstrative & Depr. & Amort Expenses | 1,370 | 1,325 | 1,150 | 1,015 | 1,057 |
Income After Depreciation & Amortization | 971 | 939 | 989 | 879 | 779 |
Non-Operating Income | 27 | 17 | 22 | 3 | 8 |
Interest Expense | 134 | 63 | 9 | 61 | 28 |
Pretax Income | 864 | 893 | 1,002 | 821 | 760 |
Income Taxes | 178 | 207 | 226 | 191 | 175 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 686 | 686 | 775 | 630 | 585 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 686 | 686 | 775 | 630 | 585 |
Depreciation Footnote | 9/30/23 | 9/30/22 | 9/30/21 | 9/30/20 | 9/30/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 1,124 | 1,074 | 1,116 | 1,007 | 877 |
Depreciation & Amortization (Cash Flow) | 153 | 136 | 127 | 128 | 98 |
Income After Depreciation & Amortization | 971 | 939 | 989 | 879 | 779 |
Earnings Per Share Data | 9/30/23 | 9/30/22 | 9/30/21 | 9/30/20 | 9/30/19 |
---|---|---|---|---|---|
Average Shares | 2,140.00 | 2,125.57 | 2,128.36 | 2,126.14 | 2,124.00 |
Diluted EPS Before Non-Recurring Items | 0.33 | 0.34 | 0.37 | 0.30 | 0.30 |
Diluted Net EPS (GAAP) | 0.32 | 0.32 | 0.36 | 0.30 | 0.27 |
Fiscal Year end for Coloplast AS Sponsored ADR falls in the month of September.
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | 959.05 | 953.91 | 909.31 | 892.38 | 873.39 |
Cost Of Goods | NA | 303.53 | 305.18 | 304.62 | 293.10 |
Gross Profit | NA | 650.38 | 604.14 | 587.76 | 580.29 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 389.45 | 363.28 | 337.35 | 342.38 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 260.93 | 240.86 | 250.41 | 237.91 |
Non-Operating Income | NA | 11.84 | 11.68 | 5.41 | 6.05 |
Interest Expense | NA | 48.37 | 30.22 | 20.60 | 33.43 |
Pretax Income | NA | 224.40 | 222.31 | 235.22 | 210.53 |
Income Taxes | NA | 49.38 | 43.44 | 49.38 | 44.09 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 182.32 | 175.01 | 178.87 | 185.84 | 166.44 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 182.32 | 175.01 | 178.87 | 185.84 | 166.44 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | 2,247.76 | 2,248.61 | 2,184.00 | 2,124.00 | 2,124.00 |
Diluted EPS Before Non-Recurring Items | 0.08 | 0.08 | 0.08 | 0.09 | 0.08 |
Diluted Net EPS (GAAP) | 0.08 | 0.08 | 0.08 | 0.09 | 0.08 |